Advisor Partners II’s Novartis NVS Stock Holding History

Advisor Partners II’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$3.25M	Buy	31,895 +5,552	+21%	+$564K	0.13%	163
2023 Q2	$2.66M	Buy	26,343 +619	+2%	+$61.9K	0.12%	158
2023 Q1	$2.37M	Buy	25,724 +2,202	+9%	+$192K	0.13%	154
2022 Q4	$2.13M	Buy	23,522 +6,426	+38%	+$541K	0.13%	164
2022 Q3	$1.3M	Buy	+17,096	New	+$1.42M	0.1%	221

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advisor Partners II's NVS Position: Q3 2023 in Review

Advisor Partners II increased its Novartis (NVS) stake by 21% in Q3 2023, buying an estimated $564K and bringing the position to 31,895 shares worth $3.25M. The position accounts for 0.13% of the portfolio, ranked #163.

Advisor Partners II first reported a position in NVS in Q3 2022 and has held it in 5 quarters since. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

Advisor Partners II held 31,895 shares of Novartis worth $3.25M as of Q3 2023.
Advisor Partners II bought 5,552 Novartis shares in Q3 2023, an estimated $564K.
Novartis made up 0.13% of Advisor Partners II's portfolio in Q3 2023, its #163 holding.
Advisor Partners II first reported a position in Novartis in Q3 2022 and has held it in 5 quarters since.
1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.